A 68-Year-Old Woman with Myelofibrosis (MF)

Abdulraheem Yacoub, MD, presents the case of a 68-year-old woman with myelofibrosis and offers his initial impressions.

An expert on myeloproliferative neoplasms gives an overview of myelofibrosis and assessing patient risk.

A myelofibrosis expert discusses the indications for treatment initiation and transplantation for patients with myelofibrosis.

Abdulraheem Yacoub, MD, details the systemic therapy options for myelofibrosis and his approach to treatment sequencing.

An expert on myelofibrosis discusses recently updated data on momelotinib, which was recently submitted for FDA approval.

A detailed overview on monitoring patients with myelofibrosis, and signs that a treatment isn’t effective.

Abdulraheem Yacoub, MD, offers closing thoughts on the future myelofibrosis treatment landscape, with a focus on treatments under investigation.